Nasal Decongestant
- Product NDC
- 68210-4224
- Requested package NDC
- 68210-4224-6
- 11-digit product format
- 682104224
- Labeler code
- 68210
- Product ID
- 68210-4224_ed853c61-ca79-4c3d-e053-2995a90aecb9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Phenylephrine Hydrochloride
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Spirit Pharmaceuticals LLC
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-11-15
- Marketing end
- 0000-00-00
- Substance
- PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68210-4224-6 | Nasal Decongestant | 60 in 1 JAR | TABLET, COATED | 60 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68210-4224 | NASAL DECONGESTANT (PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [SPIRIT PHARMACEUTICALS LLC] | 4 | Legacy NDC, 1 package rows | 20241215_e8d038a3-ce56-46b8-a163-3339bd509ee8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68210-4224-6 | 68210422406 | 60 TABLET, COATED in 1 JAR (68210-4224-6) | 2022-11-15 | 0000-00-00 | No | No | Current |